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Abstract
This work investigates the anti-inflammatory activity of
methanol extracts of four endemic Stachys (Labiatae)
taxa from the Balkans: S. beckeana Do¨rfler & Hayek,
S. anisochila Vis. et Pancˇic´, S. plumosa Griseb., and
S. alpina L. subsp. dinarica Murb. As a model of acute
inflammation, carrageenan-induced paw edema in rats
was used. Extracts, applied at doses of 50, 100, and
200mg=kg p.o., exhibited dose-dependent activity.
S. beckeana and S. anisochila extracts were the most
active ones (ED50 154.52 and 162.24mg=kg, respec-
tively), with the activity comparable with indomethacin
at doses of 2 and 4mg=kg. S. plumosa extract has
shown less-pronounced anti-inflammatory effect (ED50
220.81mg=kg). Extract of S. alpina subsp. dinarica
had the lowest efficiency, attenuating inflammation less
than 50%.
Keywords: Anti-inflammatory activity, dinarica, S. alpina
subsp., S. beckeana, S. plumosa, Stachys anisochila.
Introduction
The genus Stachys (Labiatae) comprises about 300 spe-
cies distributed in Eurasia and America, some of which
have a long traditional use as nervine, tonic, and wound
healing agents, and as astringent and antidiarrheal drugs
(Naghibi et al., 2005; Kukic´ et al., 2006a). Hence, several
pharmacological activities such as antioxidant (Couladis
et al., 2003; Kukic´ et al., 2006a), antimicrobial (Skaltsa
et al., 1999, 2003; Petrovic´ et al., 2006), anxiolytic (Rab-
bani et al., 2003, 2005), antinephritic (Hayashi et al.,
1996), and anti-inflammatory (Maleki et al., 2001;
Khanavi et al., 2005) have been attributed to genus.
This work describes the anti-inflammatory activity of
four endemic Stachys taxa from the Balkans: S. beckeana
Do¨rfler & Hayek, S. anisochila Vis. et Pancˇic´, S. plumosa
Griseb., and S. alpinaL. subsp. dinaricaMurb. S. beckeana,
growing on mountains in northern Albania, Montenegro,
Herzegovina and southern Bosnia, and S. anisochila
inhabits mountain regions in western Serbia, Bosnia,
Herzegovina, and Albania. Both species belong to a very
polymorphic S. recta L. complex. S. plumosa grows on
dry pastures and mountain rocks in southeastern Serbia,
Macedonia, western Bulgaria, and northern and central
Greece (Ball, 1976). S. alpina subsp. dinarica Murb. is
Balkan endemic (Croatia, Bosnia and Herzegovina,
Montenegro, Serbia, and southwestern Bulgaria) (Diklic´,
1974; Ball, 1976; Koeva, 1989). Our ethno-medicinal
surveys showed that some of these (e.g., S. alpina subsp.
dinarica) are used in traditional medicine for bladder
inflammation, stomach complaints, and wound healing.
In the above-mentioned taxa, various secondary meta-
bolites have been identified: glycosides of isoscutellar-
eine, hypolaetine, chrysoeriol, apigenin, and luteolin,
along with phenylethanoid glycosides, iridoids, phenolic
acids, triterpenes, and essential oils (Marin et al., 2004;
Meremeti et al., 2004; Kukic´ et al., 2006b). Previously,
essential oil of S. plumosa was assessed for its antimicro-
bial activity (Petrovic´ et al., 2006). The antioxidant
activity of methanol extracts of investigated species was
estimated, too (Kukic´ et al., 2006a).
As a model of acute inflammation in this experiment,
carrageenan-induced paw edema in rats was used.
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Materials and Methods
Plant material
The flowering aerial parts of plants were collected from
natural populations: S. beckeana from Mt. Durmitor
(Montenegro), August 2003; S. anisochila in the gorge
of Beli Rzav (western Serbia), June 2003; S. plumosa in
Jelasnicˇka klisura gorge (southeastern Serbia), June
2002; and S. alpina subsp. dinarica on Mt. Jahorina
(Bosnia and Herzegovina), July 2004. Voucher specimens
were identified by Mr. Sc. Marjan Niketic´ (custodian)
and deposited in the herbarium collection of the Natural
History Museum in Belgrade (BEO ko820033=6,
ko620041=4, ko320025=6, and ko720049=83, respectively).
Extraction
Plant material (100 g) was air-dried at room temperature
and finely ground. Each sample was bimacerated with
chloroform (3 and 2 days; plant material=solvent
ratio ¼ 1:7). The marc was further extracted in the same
way with methanol and the solvent evaporated under
reduced pressure. The obtained dry methanol extracts
of S. beckeana, S. anisochila, S. plumosa, and S. alpina
subsp. dinarica (11.66, 14.88, 12.57, and 13.94 g, respec-
tively) were used for investigations.
Anti-inflammatory activity
The carrageenan-induced rat paw edema test was
used as an experimental model for screening the anti-
inflammatory activity as reported earlier (Petrovic´ et al.,
2003). The investigated Stachys extracts, dissolved in
DMSO, were administered orally (p.o.) in doses of 50,
100, and 200mg=kg. Indomethacin, dissolved in DMSO,
was used as a reference drug in doses of 1, 2, 4, and
8mg=kg p.o. The control animals were given the vehicle
(DMSO) in a dose of 1ml=kg p.o. One hour after the
oral administration of the extracts or indomethacin,
0.1mL carrageenan-saline solution (0.5%) and saline
were injected into the plantar surface of the right and left
hind paws, respectively. The left paw served as the con-
trol (noninflamed paw). The animals were sacrificed 3 h
after the carrageenan and saline injection, and paws were
cut off for weighing. The difference in weight between
right and left paw, active drug-treated versus vehicle-
treated (control) rats, served as an indicator of the anti-
inflammatory activity.
Animals
Animal studies were conducted in accordance with the
internationally accepted principles for laboratory animal
use and care in the European Community (EEC Direc-
tive of 1986; 86=609=EEC) adopted by the Ethical
Committee of Military Medical Academy, Belgrade.
Adult male Wistar rats, weighing 200–250 g, were used
in the experiments. Experimental groups consisted of
6–10 animals each. The animals were deprived of food
for 18–20 h before the beginning of the experiments but
had free access to tap water.
Statistical analysis
Statistical analysis was performed with the Mann–
Whitney U-test and ANOVA. Differences were accepted
as statistically significant when p < 0.05.
The mean effective anti-inflammatory doses (ED50)
of extracts and indomethacin were calculated by the
method of Litchfield and Wilcoxon (1949).
Results
All investigated Stachys extracts expressed a dose-
dependent anti-inflammatory effect (Table 1). The most
prominent reduction of carrageenan-induced inflammation
was achieved at the highest dose applied. S. beckeana and
S. anisochila extracts were the most active ones. These
extracts applied at 200mg=kg p.o. suppressed inflam-
mation by 53.30% and 54.04%, with ED50 of 154.52
and 162.24mg=kg, respectively. These effects were
comparable with those achieved by 2 and 4mg=kg
of indomethacin (50.37% and 58.06%, respectively).
S. plumosa extract was slightly less active reaching the
Table 1. Anti-inflammatory effect of investigated Stachys
extracts.
Treatment
Dose
(mg=kg, p.o.)
Anti-inflammatory
effect (%)
ED50
(mg=kg)
Control (DMSO)a 1mL=kg 0.00 20.57
Indomethacinb 1 27.14 11.83 2.53
2 50.37 5.96
4 58.06 13.87
8 74.32 15.70
S. beckeana extract 50 20.65 8.97 154.52
100 45.43 10.02
200 53.30 5.72
S. anisochila extract 50 20.33 12.11 162.24
100 40.39 6.06
200 54.04 11.20
S. plumosa extract 50 25.65 7.19 220.81
100 40.65 14.23
200 46.52 14.70
S. alpina subsp.
dinarica extract
50 24.67 9.67 —
100 30.43 5.39
200 37.17 16.63
aVehicle.
bReference drug.
p < 0.05; p < 0.001 vs. control group.
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highest activity (46.52%) at maximum dose applied and
with ED50 at 220.81mg=kg. The ED50 for S. alpina
subsp. dinarica extract could not be determined, because
the uppermost dose exhibited an anti-inflammatory
effect of 37.17%.
Discussion
The obtained results are consistent with investigations
concerning some other Stachys species. S. inflata (Maleki
et al., 2001) and S. byzantina (Khanavi et al., 2005) also
attenuated carrageenan-induced rat paw edema similarly
to indomethacin (5mg=kg p.o.). Extract of aerial parts of
S. inflata exhibits a cardioprotective effect, causing a
pronounced reduction in myocardial infarct size, and
such activity is likely the result of the inhibition of
inflammatory components at the site of the reperfused
area (Garjani et al., 2004).
As previously reported, secondary metabolites in
investigated Stachys species include various compounds
(Marin et al., 2004; Meremeti et al., 2004). Many of
these compounds also demonstrated anti-inflammatory
activity. In S. plumosa, phenylethanoid glycosides acteo-
side and forsithoside B were identified (Bankova et al.,
1999), which showed selective inhibition toward the
COX-2 enzyme (Sahpaz et al., 2002). Acteoside, isolated
from S. sieboldii, had a suppressive effect on the accumu-
lation of leukocytes in the nephritic glomeruli (Hayashi
et al., 1994) and a modulating activity on NO pro-
duction, a key mediator in carregeenan-induced rat
paw edema (Ohno et al., 2002).
All investigated Stachys taxa are characterized by
the presence of several hypolaetin derivatives. It was
previously shown that hypolaetin and its 8-b-D-glucoside
are selective inhibitors of lipoxygenase activity in vitro
(Ferrandiz & Alcaraz, 1991). Few luteolin glycosides were
identified in S. plumosa (Marin et al., 2004). Flavonoids
resembling luteolin in structure (sharing 30, 40, 5, 7-tetra-
hydroxy substitution) resemble its anti-inflammatory
activity, obtained by inhibition of lipopolysaccharide-
induced TNF-a production (Ueda et al., 2004). In S. ani-
sochila and S. beckeana, harpagide and 8-acetylharpagide
were identified (Lenherr et al., 1984). These iridoids
selectively inhibit thromboxane-synthase enzyme, which
may be the primary target of their action and one of
the mechanisms through which they exert their anti-
inflammatory effects (Bermejo Benito et al., 2000).
It is reasonable to presume that presence of the above-
mentioned compounds contributes to the demonstrated
anti-inflammatory effects of investigated Stachys taxa.
Our previous experiments revealed the antioxidant and
free radical scavenging activities of the investigated
extracts (Kukic´ et al., 2006a). It is well-known that
antioxidants directly scavenge reactive oxygen species
(ROS), which have been considered to exert their
inflammatory effects via a direct toxic action on target
cells and also through gene induction and especially
through the activation of the redox-sensitive transcrip-
tion factor NF-jB (Menegazzi et al., 2005). Some antiox-
idants may also mediate their anti-inflammatory
activities by inhibiting different proinflammatory
enzymes (COX, LOX, NOS) (Sadik et al., 2003; Sala
et al., 2006) and also by preventing induction of the cyto-
kine cascade and upregulation of the expression of
adhesion molecules (Menegazzi et al., 2006). It had been
shown that the extracts of S. beckeana and S. anisochila,
the most active ones in this study, also exhibited stronger
antioxidative activity than extracts of the other two
Stachys species. Such correlation between antioxidant
activity and anti-inflammatory effects obtained in the
current study suggests that antioxidant activity of inves-
tigated Stachys extracts is at least partly involved in
their anti-inflammatory effect. However, for determining
the precise mechanisms of the anti-inflammatory action
and for recognition of active compounds responsible
for such activity, further investigations are needed.
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